Putnam BioRevolution ETF
SYNB
SYNB was delisted on the 13th of November, 2025.
3 hedge funds and large institutions have $3.92M invested in Putnam BioRevolution ETF in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
16.1% less ownership
Funds ownership: 86.28% → 70.18% (-16%)
40% less funds holding
Funds holding: 5 → 3 (-2)
44% less capital invested
Capital invested by funds: $7.03M → $3.92M (-$3.11M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$3.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GT
Glenview Trust
Louisville,
Kentucky
|
-$2.01M |
| 2 |
Jane Street
New York
|
-$766K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$585K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.98K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Franklin Resources
San Mateo,
California
| $3.88M | +$3.72M | +125,000 | New |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $41K | -$585K | -19,639 | -94% |
|
|
3
UBS Group
Zurich,
Switzerland
| $372 | -$2.98K | -100 | -89% |
|
|
GT
4
Glenview Trust
Louisville,
Kentucky
| – | -$2.01M | -69,185 | Closed |
|
|
5
Jane Street
New York
| – | -$766K | -26,326 | Closed |
|
SYNB Hedge Fund Activity: Q1 2024 in Review
3 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q1 2024, worth a combined $3.92M — down 44% from $7.03M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SYNB and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was Franklin Resources, opening a new position worth an estimated $3.72M. The largest seller was Glenview Trust, exiting entirely with an estimated $2.01M sold.
- 3 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q1 2024, down from 5 in Q4 2023.
- Funds reported $3.92M of Putnam BioRevolution ETF stock for Q1 2024, down 44% quarter-over-quarter.
- 1 fund opened new Putnam BioRevolution ETF positions in Q1 2024 and 2 closed out, a net change of -1 holder.
- The largest Putnam BioRevolution ETF buyer in Q1 2024 was Franklin Resources, an estimated $3.72M added.
- The largest Putnam BioRevolution ETF seller in Q1 2024 was Glenview Trust, an estimated $2.01M sold.
Based on aggregated 13F filings for Q1 2024.